中国生物工程杂志

［1］ Yung H T, Shu C C, Hsien F K. Histamine contents and histamineforming bacteria in natto products in Taiwan. Food Control 2007; 18: 1026~1030 ［2］ 刘向阳，杨世忠，牟伯中.微生物脂肽的结构.生物技术通报，2005，(4)：18~26 Liu X Y, Yang S Z, Mou B Z. Biotechnology Bulletin, 2005, 4: 18～26 ［3］ Arima K，Kakinuma A，Tamura G.A crystalline peptidelipid and surfactant produced by Bacillus subtilis:isolation,characterization and its inhibition of fibrin clot formation.Biochem Biophys Res Commun，1968，1：488～494 ［4］ Kowall M ，Vater J，K1uge B，et a1.J Colloid Interface Sci，1998,204(1)：1～8 ［5］ Chen Y C，Lin Y M ，Lin S C.Xingda Gongcheng Xuebao，1999，10(1)：25～33 ［6］ Yeh M S, Wei Y H, Chang J S. Bioreactor design for enhanced carrierassisted surfactin production with Bacillus subtilis. Process Biochem,2006,41:1799~1805 ［7］ Cooper D G，MacDonald C R，Duf S F B，et a1.Enhancedproduction of surfactin from Bacillus subtilis by continuous product removal and metal cation additions.Appl Environ Micro Biol，1981，42：408~412 ［8］ Kim S Y, Kim J Y, Kim S H, et al. Surfactin from Bacillus subtilis displays antiproliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression, FEBS Letters, 2007, 581(5): 865~871 ［9］ Kai L, Wang Z F, Shi Y L,et al. Opioid receptor antagonists increase［Ca2+］ in rat arterial smooth muscle cells in hemorrhagic shock. Acta Pharmacol Sin,2004,25: 395~400 ［10］ Razafindralambo H, Paquot M, Hbid C,et al. Foaming properties of lipopeptides produced by Bacillus subtilis: effect of lipid and peptide structure attributes.J Agric food Chem,1998, 46: 911~916 ［11］ Ju H K, Jun P Y, Lei Z,et al. Identification of two novel fibrinolytic enzymes from Bacillus subtilis QK02. Comparative Biochem Physio Part C,2004,137: 65~74